Aurora J. Cruz-Cabeza
TitleCited byYear
Significant progress in predicting the crystal structures of small organic molecules–a report on the fourth blind test
GM Day, TG Cooper, AJ Cruz-Cabeza, KE Hejczyk, HL Ammon, ...
Acta Crystallographica Section B: Structural Science 65 (2), 107-125, 2009
3732009
Conformational Polymorphism
AJ Cruz-Cabeza, J Bernstein
Chemical Reviews 114 (4), 2170–2191, 2014
3382014
Towards crystal structure prediction of complex organic compounds–a report on the fifth blind test
DA Bardwell, CS Adjiman, YA Arnautova, E Bartashevich, SXM Boerrigter, ...
Acta Crystallographica Section B: Structural Science 67 (6), 535-551, 2011
3302011
Facts and fictions about polymorphism
AJ Cruz-Cabeza, SM Reutzel-Edens, J Bernstein
Chemical Society Reviews 44 (23), 8619-8635, 2015
2222015
Acid–base crystalline complexes and the pKa rule
AJ Cruz-Cabeza
CrystEngComm 14, 6362-6365, 2012
1982012
Successful prediction of a model pharmaceutical in the fifth blind test of crystal structure prediction
AV Kazantsev, PG Karamertzanis, CS Adjiman, CC Pantelides, SL Price, ...
International journal of pharmaceutics 418 (2), 168-178, 2011
1042011
Prediction and observation of isostructurality induced by solvent incorporation in multicomponent crystals
AJC Cabeza, GM Day, WDS Motherwell, W Jones
Journal of the American Chemical Society 128 (45), 14466-14467, 2006
902006
Towards prediction of stoichiometry in crystalline multicomponent complexes
AJ Cruz‐Cabeza, GM Day, W Jones
Chemistry–A European Journal 14 (29), 8830-8836, 2008
712008
Predicting stoichiometry and structure of solvates
AJ Cruz-Cabeza, S Karki, L Fabian, T Friščić, GM Day, W Jones
Chemical Communications 46 (13), 2224-2226, 2010
682010
Amide pyramidalization in carbamazepine: A flexibility problem in crystal structure prediction?
AJC Cabeza, GM Day, WDS Motherwell, W Jones
Crystal growth & design 6 (8), 1858-1866, 2006
632006
Importance of molecular shape for the overall stability of hydrogen bond motifs in the crystal structures of various carbamazepine-type drug molecules
AJC Cabeza, GM Day, WDS Motherwell, W Jones
Crystal growth & design 7 (1), 100-107, 2007
622007
Solvation and surface effects on polymorph stabilities at the nanoscale
AM Belenguer, GI Lampronti, AJ Cruz-Cabeza, CA Hunter, JKM Sanders
Chemical science 7 (11), 6617-6627, 2016
602016
Predicting inclusion behaviour and framework structures in organic crystals
AJ Cruz‐Cabeza, GM Day, W Jones
Chemistry–A European Journal 15 (47), 13033-13040, 2009
572009
Identification, classification and relative stability of tautomers in the cambridge structural database
AJ Cruz-Cabeza, CR Groom
CrystEngComm 13 (1), 93-98, 2011
472011
Solvent inclusion in form II carbamazepine
AJC Cabeza, GM Day, WDS Motherwell, W Jones
Chemical Communications, 1600-1602, 2007
422007
Pharmaceutical hydrates under ambient conditions from high-pressure seeds: A case study of GABA monohydrate
FPA Fabbiani, G Buth, DC Levendis, AJ Cruz-Cabeza
Chemical Communications 50 (15), 1817-1819, 2014
412014
Is the fenamate group a polymorphophore? Contrasting the crystal energy landscapes of fenamic and tolfenamic acids
OG Uzoh, AJ Cruz-Cabeza, SL Price
Crystal Growth & Design 12 (8), 4230-4239, 2012
402012
Metal-exchanged β zeolites as catalysts for the conversion of acetone to hydrocarbons
AJ Cruz-Cabeza, D Esquivel, C Jiménez-Sanchidrián, ...
Materials 5 (1), 121-134, 2012
382012
Controlling molecular tautomerism through supramolecular selectivity
K Epa, CB Aakeröy, J Desper, S Rayat, KL Chandra, AJ Cruz-Cabeza
Chemical Communications 49 (72), 7929-7931, 2013
282013
Can the study of self-assembly in solution lead to a good model for the nucleation pathway? The case of tolfenamic acid.
W Du, AJ Cruz-Cabeza, S Woutersen, RJ Davey, Q Yin
Chemical science 6 (6), 3515-3524, 2015
272015
The system can't perform the operation now. Try again later.
Articles 1–20